James B. Breitmeyer

Insider Reports History

Entity
Individual
Signature
/s/Chase C. Leavitt, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James B. Breitmeyer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Oncternal Therapeutics, Inc. Chief Executive Officer, Director Common Stock 443K $220K $0.50 Jan 3, 2024 Direct
Oncternal Therapeutics, Inc. Chief Executive Officer, Director Common Stock 197K $97.5K $0.50 Jan 3, 2024 By Family Trust
Oncternal Therapeutics, Inc. Chief Executive Officer, Director Common Stock 15.4K $7.65K $0.50 Jan 3, 2024 By Spouse
Oncternal Therapeutics, Inc. Chief Executive Officer, Director Common Stock 733 $364 $0.50 Jan 3, 2024 By Child
Oncternal Therapeutics, Inc. Chief Executive Officer, Director Stock Option 28.4K Feb 14, 2024 Direct
OTONOMY, INC. Director Stock Option (right to buy) 27.5K Jun 21, 2022 Direct
Oncternal Therapeutics, Inc. Chief Executive Officer, Director Stock Option 6.2K Feb 14, 2024 By Spouse
ZOGENIX, INC. Director Common Stock 0 $26.04 Mar 7, 2022 Direct
ZOGENIX, INC. Director Stock Option (Right to Buy) 0 $26.09 Mar 7, 2022 Direct

Insider Reports Filed by James B. Breitmeyer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ONCT Oncternal Therapeutics, Inc. Feb 14, 2024 2 $0 4 Feb 15, 2024 Chief Executive Officer, Director
ONCT Oncternal Therapeutics, Inc. Jan 3, 2024 2 -$27.5K 4 Jan 5, 2024 Chief Executive Officer, Director
ONCT Oncternal Therapeutics, Inc. Oct 2, 2023 24 $0 4 Oct 4, 2023 Chief Executive Officer, Director
ONCT Oncternal Therapeutics, Inc. Jul 3, 2023 2 -$18.7K 4 Jul 5, 2023 Chief Executive Officer, Director
ONCT Oncternal Therapeutics, Inc. Apr 13, 2023 3 $43.9K 4 Apr 17, 2023 Chief Executive Officer, Director
ONCT Oncternal Therapeutics, Inc. Feb 21, 2023 3 $0 4 Feb 24, 2023 Chief Executive Officer, Director
ONCT Oncternal Therapeutics, Inc. Jan 3, 2023 2 -$29.7K 4 Jan 5, 2023 Chief Executive Officer, Director
ONCT Oncternal Therapeutics, Inc. Jul 28, 2022 4 $0 4 Aug 1, 2022 Chief Executive Officer, Director
OTIC OTONOMY, INC. Jun 21, 2022 1 $0 4 Jun 23, 2022 Director
ZGNX ZOGENIX, INC. Mar 7, 2022 7 $0 4 Mar 9, 2022 Director
ONCT Oncternal Therapeutics, Inc. Jan 27, 2022 1 $42.1K 4 Jan 31, 2022 Chief Executive Officer, Director
ONCT Oncternal Therapeutics, Inc. Jan 20, 2022 2 $0 4 Jan 24, 2022 Chief Executive Officer, Director
ONCT Oncternal Therapeutics, Inc. Jan 3, 2022 2 $0 4 Jan 5, 2022 Chief Executive Officer, Director
OTIC OTONOMY, INC. Jun 22, 2021 1 $0 4 Jun 24, 2021 Director
ZGNX ZOGENIX, INC. May 27, 2021 1 $0 4 May 28, 2021 Director